NO20031066D0 - Metode for utseparering av vira fra en proteinlösning ved hjelp av nanofiltrering - Google Patents

Metode for utseparering av vira fra en proteinlösning ved hjelp av nanofiltrering

Info

Publication number
NO20031066D0
NO20031066D0 NO20031066A NO20031066A NO20031066D0 NO 20031066 D0 NO20031066 D0 NO 20031066D0 NO 20031066 A NO20031066 A NO 20031066A NO 20031066 A NO20031066 A NO 20031066A NO 20031066 D0 NO20031066 D0 NO 20031066D0
Authority
NO
Norway
Prior art keywords
nanofiltration
protein solution
separating viruses
viruses
separating
Prior art date
Application number
NO20031066A
Other languages
English (en)
Other versions
NO20031066L (no
NO326670B1 (no
Inventor
Thomas Lengsfeld
Heinrich Schneider
Original Assignee
Aventis Behring Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7714123&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20031066(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Behring Gmbh filed Critical Aventis Behring Gmbh
Publication of NO20031066D0 publication Critical patent/NO20031066D0/no
Publication of NO20031066L publication Critical patent/NO20031066L/no
Publication of NO326670B1 publication Critical patent/NO326670B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Water Supply & Treatment (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20031066A 2002-03-15 2003-03-07 Metode for utseparering av virus fra en proteinlosning ved hjelp av nanofiltrering. NO326670B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10211632A DE10211632A1 (de) 2002-03-15 2002-03-15 Verfahren zur Abtrennung von Viren aus einer Proteinlösung durch Nanofiltration

Publications (3)

Publication Number Publication Date
NO20031066D0 true NO20031066D0 (no) 2003-03-07
NO20031066L NO20031066L (no) 2003-09-16
NO326670B1 NO326670B1 (no) 2009-01-26

Family

ID=7714123

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031066A NO326670B1 (no) 2002-03-15 2003-03-07 Metode for utseparering av virus fra en proteinlosning ved hjelp av nanofiltrering.

Country Status (10)

Country Link
US (1) US7919592B2 (no)
EP (1) EP1348445B1 (no)
JP (1) JP4495404B2 (no)
KR (1) KR100998158B1 (no)
AU (1) AU2003200981B2 (no)
CA (1) CA2421681C (no)
DE (1) DE10211632A1 (no)
DK (1) DK1348445T3 (no)
ES (1) ES2410155T3 (no)
NO (1) NO326670B1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT501088A2 (de) * 2002-12-18 2006-06-15 Bio Prod & Bio Eng Ag Stabile therapeutische proteine
ES2214967B1 (es) * 2003-03-06 2005-06-16 Probitas Pharma, S.A Procedimiento para la eliminacion de virus en soluciones de fibrinogeno y fibrinogeno obtenido por dicho procedimiento.
FR2861395B1 (fr) 2003-10-23 2006-02-17 Lab Francais Du Fractionnement Facteur viii viralement securise a faible teneur en multimeres superieurs
WO2005054275A2 (en) 2003-12-01 2005-06-16 Novo Nordisk Health Care Ag Nanofiltration of factor vii solutions to remove virus
FR2866890B1 (fr) 2004-02-27 2008-04-04 Lab Francais Du Fractionnement Procede de purification d'albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant
GB0413630D0 (en) * 2004-06-18 2004-07-21 Avecia Ltd Process
US7776821B2 (en) * 2004-10-21 2010-08-17 Statens Serum Institut Method comprising nanofiltration to obtain an MBL product safe from infectious agents and the product obtainable by this method
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
ES2257225B1 (es) * 2006-02-17 2007-03-16 Grifols, S.A Preparacion terapeutica de fviia de muy alta pureza y metodo para su obtencion.
US20090186395A1 (en) * 2006-06-26 2009-07-23 Israel Nur Virus Removal by Nanofiltration
EP2043767B1 (en) 2006-07-14 2020-03-25 Wisconsin Alumni Research Foundation Adsorptive membranes for trapping viruses
WO2009149067A1 (en) * 2008-06-03 2009-12-10 Patrys Limited Process for purification of antibodies
JP5755136B2 (ja) 2009-03-27 2015-07-29 旭化成メディカル株式会社 高濃度モノクローナル抗体溶液中のウイルス除去方法
RU2603103C2 (ru) 2010-09-20 2016-11-20 Октафарма Аг Способ получения фибриногена с использованием сильной анионообменной смолы и содержащий фибриноген продукт
EP2725033B1 (en) 2011-06-24 2017-08-09 Asahi Kasei Medical Co., Ltd. Method for producing protein preparation
EP2825555B1 (en) 2012-03-13 2017-07-12 Octapharma AG Mproved process for production of fibrinogen and fibrinogen produced thereby
US9534029B2 (en) 2012-10-03 2017-01-03 Csl Behring Ag Method of purifying proteins
KR102231613B1 (ko) 2012-10-03 2021-03-25 체에스엘 베링 아게 단백질 정제 방법
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution
US20140154233A1 (en) 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
PL3030578T3 (pl) 2013-08-08 2018-12-31 Csl Limited Sposób usuwania zanieczyszczeń
KR20200038309A (ko) * 2017-08-23 2020-04-10 체에스엘 베링 게엠베하 폰 빌레브란트 인자의 바이러스 여과 방법
FR3090321B1 (fr) * 2018-12-21 2023-07-14 Lab Francais Du Fractionnement Procédé de filtration du fibrinogène

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096872A (en) * 1997-10-14 2000-08-01 Ortho Diagnostic Systems, Inc. Viral clearance process
US5981254A (en) * 1997-10-30 1999-11-09 Haemacure Corporation Process for producing thrombin from plasma
FR2772381B1 (fr) * 1997-12-15 2001-06-08 Lab Francais Du Fractionnement Procede de preparation par filtration d'une solution de facteur viii securisee viralement
FI106465B (fi) * 1998-06-10 2001-02-15 Suomen Punainen Risti Veripalv Menetelmä virusturvallisten farmaseuttisten koostumusten valmistamiseksi
US7276235B2 (en) 1998-11-18 2007-10-02 Zlb Behring Gmbh Tissue glue with improved antiadhesive properties
ES2258870T3 (es) * 1998-11-18 2006-09-01 Zlb Behring Gmbh Preparados proteicos estabilizados para un adhesivo para tejidos.
EP1250929A4 (en) * 1999-12-20 2004-12-29 Mitsubishi Pharma Corp BY POROUS MEMBRANE-TREATED, VIRUS-FREE PLASMA PROTEIN COMPOUND AND ITS MANUFACTURING PROCESS
DE10012732A1 (de) * 2000-03-18 2001-09-20 Aventis Behring Gmbh Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung
DE10022092A1 (de) 2000-05-08 2001-11-15 Aventis Behring Gmbh Stabilisiertes Protein-Präparat und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
ES2410155T3 (es) 2013-07-01
KR20030074461A (ko) 2003-09-19
EP1348445B1 (de) 2013-04-10
EP1348445A1 (de) 2003-10-01
DE10211632A1 (de) 2003-10-09
NO20031066L (no) 2003-09-16
KR100998158B1 (ko) 2010-12-06
DK1348445T3 (da) 2013-07-01
JP2003274941A (ja) 2003-09-30
AU2003200981A1 (en) 2003-10-02
US20030232969A1 (en) 2003-12-18
CA2421681A1 (en) 2003-09-15
JP4495404B2 (ja) 2010-07-07
NO326670B1 (no) 2009-01-26
AU2003200981B2 (en) 2008-11-20
CA2421681C (en) 2012-01-03
US7919592B2 (en) 2011-04-05

Similar Documents

Publication Publication Date Title
NO20031066L (no) Metode for utseparering av vira fra en proteinlösning ved hjelp av nanofiltrering
ATE369201T1 (de) Verfahren zur reinigung von synthesegas
NO20025848L (no) Fremgangsmåte for oksygenseparasjon ved keramiske komposittmembraner
PT1366231E (pt) Metodo para separacao de hemiceluloses a partir de biomassa contendo hemiceluloses
DK1592793T3 (da) Oligomeriske forbindelser for modulation af Survivin ekspression
ATE401289T1 (de) Verfahren zur abtrennung von polaren verunreinigungen aus aromatischen beschickungen
EP1633321A4 (en) METHOD FOR CLEANING VIRUS
DE60322857D1 (de) Neues alpha-amino-n-(diaminophosphinyl)lactamderivat
DE60335733D1 (de) Verfahren zur solubilisierung von protein
DK2253701T3 (da) Fremgangsmåde til ekstraktion af en virus fra en cellekultur
NO20051952D0 (no) Fremgangsmate og system for a separere en komponent fra en flerkomponentgass
DK1715753T3 (da) Fremgangsmåde til fremstilling af et risproteinkoncentrat af höj renhed
DK1456281T3 (da) Fremgangsmåde til genvinding af en polymer fra en oplösning
DK1562429T3 (da) Fremgangsmåde til forögelse af udbytte hos glyphosatresistente bælgplanter
DE602004024402D1 (de) Verfahren zur herstellung von tetrazolderivaten au
DE50109309D1 (de) Verfahren zur trennung von pentennitril-isomeren
DE502004001216D1 (de) Verfahren zur aufreinigung von blausäure
DK1575941T3 (da) Fremgangsmåde til fremstilling af (S)-pantoprazol
AU2003235595A8 (en) Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to hiv-1 rna
FI20030963A0 (fi) Erotusmenetelmä
EP1673153A4 (en) PARALLEL PROCESS FOR PROTEIN OR VIRUS SEPARATION FROM A SAMPLE
DE602005015492D1 (de) Verbessertes verfahren zur aufreinigung von perindopril
DK1453527T3 (da) Fremgangsmåde til udvinding af estrogener fra hoppeurin
DE60217413D1 (de) Verfahren zum abtrennen mehrerer hausnetze
DK1678188T3 (da) Fremgangsmåde til udvinding af krystallinsk produkt fra oplösning

Legal Events

Date Code Title Description
MK1K Patent expired